Zhang Li, An Guo-Yao, Zhang Wen-Guang, Chen Kai
Key Laboratory of Ministry of Education of the People's Republic of China, School of Orthopaedics and Traumatology of TCM, Fujian University of Traditional Chinese Medicine, Fuzhou 351008, Fujian, China.
Zhongguo Gu Shang. 2012 Dec;25(12):1016-20.
To observe effects of Tanshinone- II A sulfonate on expression of Nuclear factor-kappaB (NF-kappaB), Vascular Cell Adhesion Molecule-1 (VCAM-1) and hemorrheology during spinal cord ischemia reperfusion injury,and explore the function and mechnism.
Fifty-four New Zealand rabbits (aged 3 months,weighted 2.0 +/- 0.2 kg) were randomly divided into 6 in sham group (lumbar artery were separated in operation,0.8 ml/kg saline were injected at 0.5 h before and after operation), 24 in ischemia group ( lumbar artery were clipped after seperation, and the same dose of saline), 24 in Tanshinone group (lumbar artery were clipped after seperation, and the same dose of Tanshinone- II A sulfonate) . Abdomincal aorta blood were drawed after treatment respectively at 0.5 h, 1 h, 4 h and 8 h, and tesetd whole blood viscosity [high cut (mpa.s)/150(l/s), middle cut (mpa.s)/60(l/s) and low cut (mpa.s)/10(l/s)], capillary plasma viscosity, red cell aggregation index, rigid index, deformation index and electrophoresis index. Spinal cord tissues were divided into two sections,one fixed in 4% paraformaldehyde, another stored in liquid nitrogen. Immunohistochemical method and ELISA were used to test change of content of NF-kappaB and VCAM-1.
Tanshinone-II A sulfonate can relieve spinal cord ischemia reperfusion injury by regulating expression of NF-kappaB, VCAM-1, decreasing whole blood viscosity, capillary plasma viscosity, red cell aggregation index, rigid index, and improve hemorhelogy.
观察丹参酮ⅡA磺酸钠对脊髓缺血再灌注损伤时核因子-κB(NF-κB)、血管细胞黏附分子-1(VCAM-1)表达及血液流变学的影响,探讨其作用及机制。
将54只3月龄、体重2.0±0.2kg的新西兰兔随机分为假手术组6只(术中分离腰动脉,手术前后0.5h各注射0.8ml/kg生理盐水)、缺血组24只(分离后夹闭腰动脉,注射等量生理盐水)、丹参酮组24只(分离后夹闭腰动脉,注射等量丹参酮ⅡA磺酸钠)。分别于处理后0.5h、1h、4h、8h抽取腹主动脉血,检测全血黏度[高切(mpa.s)/150(l/s)、中切(mpa.s)/60(l/s)、低切(mpa.s)/10(l/s)]、毛细血管血浆黏度、红细胞聚集指数、刚性指数、变形指数及电泳指数。脊髓组织分为两段,一段用4%多聚甲醛固定,另一段液氮保存。采用免疫组化法和ELISA检测NF-κB和VCAM-1含量变化。
1)丹参酮组NF-κB表达最低,缺血组最高。2)与假手术组比较,缺血组不同时间VCAM-1明显升高,尤其在0.5、1、4h(P<0.01),8h有意义(P<0.05)。丹参酮组与缺血组比较,0.5h时VCAM-1明显降低(P<0.01),1、4、8h有意义(P<0.05)。3)假手术组无血管阳性表达,丹参酮组和缺血组0.5h时有表达。缺血组血管阳性表达最高在1、4、8h,缺血组与丹参酮组比较1、4h有显著意义(P<0.05),8h最明显。4)缺血组全血黏度在10s-1、60s-1、150s-1时最高,毛细血管黏度升高(P<0.05或P<0.01)。而丹参酮组毛细血管黏度、红细胞聚集指数、刚性指数、变形指数明显降低(P<0.01)。
丹参酮ⅡA磺酸钠可通过调节NF-κB、VCAM-1表达,降低全血黏度、毛细血管血浆黏度、红细胞聚集指数、刚性指数,改善血液流变学,减轻脊髓缺血再灌注损伤。